Lung cancer is the leading cause of cancer-related death worldwide. However, lung cancer
incidence and mortality rates differ substantially across the world, reflecting varying patterns …

Randomised controlled trials, including the National Lung Screening Trial (NLST) and the
NELSON trial, have shown reduced mortality with lung cancer screening with low-dose CT …

Background: There are well-documented disparities in lung cancer outcomes across
populations. Lung cancer screening (LCS) has the potential to reduce lung cancer mortality …

As the popularity and diversity of social media platforms increases so does their utility for
health research. Using social media for recruitment into clinical studies and/or delivering …

Importance To be effective in reducing deaths from lung cancer among high-risk current and
former smokers, screening with low-dose computed tomography must be performed …

Lung cancer remains the leading cause of cancer mortality in the United States. Lung cancer
screening (LCS) with low-dose CT reduces mortality among high-risk current and former …

Rationale: Low uptake of low-dose computed tomography (LDCT) lung cancer screening,
particularly by current smokers of a low socioeconomic position, compromises effectiveness …

The public health imperative to reduce the burden of lung cancer has seen unprecedented
progress in recent years. Fully realizing the advances in lung cancer treatment and control …

Background While discussion continues over the future implementation of lung cancer
screening, low participation from higher risk groups could limit the effectiveness of any …

Lung cancer is the leading cause of cancer-related deaths in Europe, with low survival rates
primarily due to late-stage diagnosis. Early detection can significantly improve survival rates …